Polycythemia Vera: all 238 studies
Page 3 of 3. Open to participants first (57), then studies with results posted, then the rest; newest registration first within each.
- A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid NeoplasmsCompletedNCT01387763Phase 3
- LBH589 (Panobinostat) for the Treatment of MyelofibrosisStatus unknownNCT01298934Phase 1/2
- Natural Killer Cells and Polycythemia Vera (Vaquez's Disease)Status unknownNCT01284712
- Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)CompletedNCT01259817Phase 2
- Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia VeraCompletedNCT01243073Phase 2
- Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)CompletedNCT01236638Phase 2
- Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantActive, not recruitingNCT01199562
- Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia VeraCompletedNCT01193699Phase 1/2
- A Study in Myeloproliferative DisordersCompletedNCT01134120Phase 1
- Treatment of Polycythemia Vera With GleevecCompletedNCT01120821Phase 2
- Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for CancerCompletedNCT01053494Not applicable
- Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With MyelofibrosisTerminatedNCT01014546Phase 1
- Clopidogrel and Aspirin for the Treatment of Polycythemia VeraWithdrawnNCT00940784Phase 2
- Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)CompletedNCT00935987Phase 1/2
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerActive, not recruitingNCT00935090
- Studying Fentanyl in Patients With CancerTerminatedNCT00899951
- Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
- A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential ThrombocythaemiaStatus unknownNCT00866762Phase 2
- A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic MyelofibrosisCompletedNCT00745550Phase 1/2
- Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET GenesCompletedNCT00715247
- CEP-701 (Lestaurtinib) in MyelofibrosisStatus unknownNCT00668421Phase 1/2
- Research Tissue BankCompletedNCT00666549
- Familial Myeloproliferative DisordersCompletedNCT00666289
- Correlative Biomarker Study in Patients With Myeloproliferative DisordersCompletedNCT00665067
- A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With MyelofibrosisCompletedNCT00631462Phase 1
- A Phase 1 Study of XL019 in Adults With Polycythemia VeraTerminatedNCT00595829Phase 1
- Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative DisordersCompletedNCT00588991Phase 1
- Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential ThrombocytosisCompletedNCT00586651Phase 2
- A Safety Study of XL019 in Adults With MyelofibrosisTerminatedNCT00522574Phase 1
- Molecular Changes and Biomarkers in Chronic Myeloproliferative DisordersCompletedNCT00433862
- Effects of Imatinib Mesylate in Polycythemia VeraCompletedNCT00430066Phase 2
- Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative DisordersCompletedNCT00357305Phase 1
- Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia VeraCompletedNCT00241241Phase 2
- Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell TransplantationCompletedNCT00052520Phase 1/2
- Tipifarnib in Treating Patients With Myelofibrosis and Myeloid MetaplasiaCompletedNCT00047190Phase 2
- Imatinib Mesylate in Treating Patients With MyelofibrosisCompletedNCT00039416Phase 2
- Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00025415Phase 1
- Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1